Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

3.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.3K
Therapeutic Index01:13

Therapeutic Index

5.9K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
5.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

613
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
613
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

5.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factor XII locking in (for contact activation through disulfide control).

Journal of thrombosis and haemostasis : JTH·2026
Same author

Intravenous lanadelumab for the treatment of moderately ill COVID-19 patients.

British journal of clinical pharmacology·2026
Same author

Plasmin-mediated proteolysis of von Willebrand factor in patients with acute and chronic liver disease.

Research and practice in thrombosis and haemostasis·2025
Same author

<i>In vivo</i> activation of coagulation during human liver transplantation is associated with activation of the intrinsic pathway: an observational cohort study.

Research and practice in thrombosis and haemostasis·2025
Same author

Author Correction: Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies.

Scientific reports·2025
Same author

Factor XII contact activation can be prevented by targeting 2 unique patches in its epidermal growth factor-like 1 domain with a nanobody.

Journal of thrombosis and haemostasis : JTH·2024

Related Experiment Video

Updated: Nov 8, 2025

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

431

Therapeutic SERPINs: Improving on Nature.

Coen Maas1, Steven de Maat1

  • 1CDL Research, University Medical Center Utrecht, Utrecht, Netherlands.

Frontiers in Cardiovascular Medicine
|April 19, 2021
PubMed
Summary

Serine protease inhibitors (SERPINs) regulate vital bodily functions. Engineering these SERPINs, through modifications like reactive center loop changes, offers a promising avenue for developing next-generation therapeutics to treat SERPIN deficiencies.

Keywords:
C1 esterase inhibitorSERPINreactive center looptherapyα1-antitrypsin

More Related Videos

Author Spotlight: Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus
06:45

Author Spotlight: Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus

Published on: June 2, 2023

2.5K
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

702

Related Experiment Videos

Last Updated: Nov 8, 2025

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

431
Author Spotlight: Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus
06:45

Author Spotlight: Affinity Purification of a Fibrinolytic Enzyme from Sipunculus nudus

Published on: June 2, 2023

2.5K
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

702

Area of Science:

  • Biochemistry and Molecular Biology
  • Protease-Inhibitor Interactions
  • Drug Discovery and Development

Background:

  • Serine proteases are crucial for physiological processes including coagulation, fibrinolysis, inflammation, and angiogenesis.
  • Serine protease inhibitors (SERPINs) are natural regulators of serine protease activity; human deficiency in SERPINs can cause disease.
  • Existing SERPIN replacement therapies include plasma-derived and recombinant SERPINs, but therapeutic potential remains limited.

Purpose of the Study:

  • To review the current state of SERPIN engineering for therapeutic applications.
  • To highlight advancements in understanding SERPIN biological functions, inhibitory mechanisms, and specificity.
  • To explore novel strategies for developing future generations of therapeutic SERPINs.

Main Methods:

  • Review of existing literature on SERPIN biology, function, and engineering.
  • Focus on rational design approaches, specifically reactive center loop modifications and backbone stabilization.
  • Analysis of lessons learned from recombinant SERPIN development and application.

Main Results:

  • Significant progress has been made in identifying SERPIN functions and inhibitory mechanisms.
  • Rational design allows for optimization of SERPIN inhibitory properties, including selectivity and potency.
  • Recombinant SERPIN engineering demonstrates potential for therapeutic development.

Conclusions:

  • SERPIN engineering holds significant promise for creating advanced therapeutic agents.
  • Further research into novel techniques and strategies is essential for the future generation of therapeutic SERPINs.
  • Optimized SERPINs could address unmet needs in treating various diseases linked to protease dysregulation.